Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxychloroquine for Atrial Fibrillation Recurrence After Ablation
NCT03592823Phase 4Unknown
- Sponsor
- The First Affiliated Hospital of Harbin Medical University
- Start
- Aug 2018
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of hydroxychloroquine in Atrial fibrillation (AFib), sponsored by The First Affiliated Hospital of Harbin Medical University. Status: unknown.
02
Drugs
hydroxychloroquine
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT03592823.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03592823.